том 36 издание 2 страницы 253-259

Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking

Тип публикацииJournal Article
Дата публикации2014-03-18
scimago Q1
wos Q1
БС1
SJR2.945
CiteScore19.3
Impact factor9.2
ISSN18632297, 18632300
Immunology
Immunology and Allergy
Краткое описание
Cystein-rich protein 61 (CYR61/CCN1) is a component of the extracellular matrix, which is produced and secreted by several cell types including endothelial cells, fibroblasts and smooth muscle cells. CCN1 has been implicated in leukocyte migration and the inflammatory process, but it is also involved in cardiovascular development and carcinogenesis. It exerts its functions through binding to multiple integrins present in many different cell types. This multiplicity in function is now known to contribute to the diverse array of cellular processes it can regulate. The expression of CCN1 is tightly regulated by cytokines and growth factors. However, CCN1 can directly modulate cell adhesion and migratory processes whilst simultaneously regulating the production of other cytokines and chemokines through paracrine and autocrine feedback loops. This complex functionality of CCN1 has highlighted the pivotal role this molecule can play in regulating the immunosurveillance process. Furthermore, CCN1 has now emerged as an important partner when targeting components of the infectious or chronic inflammatory disease processes such as atherosclerosis or rheumatoid arthritis. This review will focus on CYR61/CCN1 and its ability to control the migration of leukocytes, the production of cytokines and cell proliferation or senescence at the site of inflammation.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

1
2
3
Matrix Biology
3 публикации, 3.53%
Molecular Medicine Reports
2 публикации, 2.35%
Frontiers in Medicine
2 публикации, 2.35%
Journal of Cell Communication and Signaling
2 публикации, 2.35%
Scientific Reports
2 публикации, 2.35%
Biochemical and Biophysical Research Communications
2 публикации, 2.35%
Gene
2 публикации, 2.35%
Mendeleev Communications
2 публикации, 2.35%
Mediators of Inflammation
2 публикации, 2.35%
Beilstein Journal of Organic Chemistry
1 публикация, 1.18%
Journal of Clinical Investigation
1 публикация, 1.18%
Medecine/Sciences
1 публикация, 1.18%
Biomarkers in Medicine
1 публикация, 1.18%
Journal of the Royal Society Interface
1 публикация, 1.18%
Journal for ImmunoTherapy of Cancer
1 публикация, 1.18%
Oncology Letters
1 публикация, 1.18%
Journal of the American Heart Association
1 публикация, 1.18%
Innate Immunity
1 публикация, 1.18%
International Journal of Molecular Sciences
1 публикация, 1.18%
Biomolecules
1 публикация, 1.18%
Transplant International
1 публикация, 1.18%
Frontiers in Cardiovascular Medicine
1 публикация, 1.18%
Frontiers in Oncology
1 публикация, 1.18%
Acta neuropathologica communications
1 публикация, 1.18%
BMC Gastroenterology
1 публикация, 1.18%
Nature Cell Biology
1 публикация, 1.18%
Seminars in Immunopathology
1 публикация, 1.18%
Translational Psychiatry
1 публикация, 1.18%
Bulletin of Mathematical Biology
1 публикация, 1.18%
1
2
3

Издатели

5
10
15
20
Elsevier
20 публикаций, 23.53%
Springer Nature
14 публикаций, 16.47%
Wiley
8 публикаций, 9.41%
Frontiers Media S.A.
5 публикаций, 5.88%
MDPI
4 публикации, 4.71%
Taylor & Francis
3 публикации, 3.53%
Spandidos Publications
3 публикации, 3.53%
Hindawi Limited
3 публикации, 3.53%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 публикации, 2.35%
Oxford University Press
2 публикации, 2.35%
Cold Spring Harbor Laboratory
2 публикации, 2.35%
Ovid Technologies (Wolters Kluwer Health)
2 публикации, 2.35%
Beilstein-Institut
1 публикация, 1.18%
American Society for Clinical Investigation
1 публикация, 1.18%
Editions E D K
1 публикация, 1.18%
The Royal Society
1 публикация, 1.18%
BMJ
1 публикация, 1.18%
SAGE
1 публикация, 1.18%
American Chemical Society (ACS)
1 публикация, 1.18%
American Physiological Society
1 публикация, 1.18%
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 1.18%
AME Publishing Company
1 публикация, 1.18%
Impact Journals
1 публикация, 1.18%
American Association for the Advancement of Science (AAAS)
1 публикация, 1.18%
5
10
15
20
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
85
Поделиться
Цитировать
ГОСТ |
Цитировать
Emre Y., Imhof B. A. Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking // Seminars in Immunopathology. 2014. Vol. 36. No. 2. pp. 253-259.
ГОСТ со всеми авторами (до 50) Скопировать
Emre Y., Imhof B. A. Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking // Seminars in Immunopathology. 2014. Vol. 36. No. 2. pp. 253-259.
RIS |
Цитировать
TY - JOUR
DO - 10.1007/s00281-014-0420-1
UR - https://doi.org/10.1007/s00281-014-0420-1
TI - Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking
T2 - Seminars in Immunopathology
AU - Emre, Yalin
AU - Imhof, Beat A.
PY - 2014
DA - 2014/03/18
PB - Springer Nature
SP - 253-259
IS - 2
VL - 36
PMID - 24638890
SN - 1863-2297
SN - 1863-2300
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2014_Emre,
author = {Yalin Emre and Beat A. Imhof},
title = {Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking},
journal = {Seminars in Immunopathology},
year = {2014},
volume = {36},
publisher = {Springer Nature},
month = {mar},
url = {https://doi.org/10.1007/s00281-014-0420-1},
number = {2},
pages = {253--259},
doi = {10.1007/s00281-014-0420-1}
}
MLA
Цитировать
Emre, Yalin, and Beat A. Imhof. “Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking.” Seminars in Immunopathology, vol. 36, no. 2, Mar. 2014, pp. 253-259. https://doi.org/10.1007/s00281-014-0420-1.